Description
AOD9604 is a modified fragment of human growth hormone studied for its lipolytic (fat-reducing) activity. Research indicates it does not significantly impact insulin or IGF-1 levels, and it has not been shown to trigger antibody formation. AOD9604 remains under investigation and is supplied strictly for research use only.
Reviews
There are no reviews yet.